UBS Group Reduces $134M in Amrize Ltd ($AMRZ)
Key Points
- UBS Group changed its Amrize Ltd ($AMRZ) stake by 18.8% last quarter, cutting to 10,929,766 shares worth $578.29 million.
- Wall Street's consensus rating on $AMRZ is Buy and an average price target of $64.91.
- $AMRZ last traded around $52.91.
UBS Group reduced its position in Amrize Ltd ($AMRZ) by 18.8% during the most recent quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 10,929,766 shares of Amrize Ltd after selling 2,536,040 shares during the quarter. UBS Group's holdings in Amrize Ltd were worth $578.29 million as of its most recent filing.
Amrize Ltd ($AMRZ) Stock
Amrize Ltd Earnings
Amrize Ltd Dividend
Analysts Set New Price Targets
About Amrize Ltd
Amrize AG engages in the provision of various building solutions for infrastructure, commercial, and residential construction markets in North America. It operates through two segments, Building Materials and Building Envelope. The Building Materials segment offers cement and aggregates, as well as ready-mix concrete, asphalt, and other construction materials. The Building Envelope segment provides advanced roofing and wall systems, including single-ply membranes, insulation, shingles, sheathing, waterproofing, and protective coatings; and adhesives, tapes, and sealants. The company was formerly known as Holcim North America Finance Ltd and changed its name to Amrize AG in December 2013. Amrize AG was incorporated in 2023 and is based in Zug, Switzerland.
See Also
This instant news alert was generated by automated narrative technology and financial data from Opentrades and public regulatory filings. It is for informational purposes only and is not financial advice.